A false advertising class-action lawsuit was filed against Lung Institute, a company that operates medical offices and provides stem cell therapy procedures. The complaint, which was originally filed in 2016 and amended in December 2017, alleges that the company misleadingly advertises that its procedures “repair[], replace[], and regenerate[]” lung tissue and treats serious diseases – including COPD and Crohn’s Disease – without any scientifically credible evidence to support such claims. Plaintiffs also claim that the company “masquerad[es]” as a medical institute and its “medical directors” are not pulmonologists. The case was transferred from state court to federal court in December 2017. (Rivero et al v. Lung Institute, LLC, Case No. 17-cv-3113, M. D. FL.)


The Latest

Filters

Bumbu Rum

Ad Alert

Bumbu Rum

Lawsuit alleges beverage doesn’t meet federal standards to be marketed as rum.

Lomi

Ad Alert

Lomi

TINA.org digs into company’s broad composting claims.

TruHeight

Ad Alert

TruHeight

Company marketing ‘height growth vitamins’ makes some tall claims.


Show More